Most cited papers from Oxurion (Belgium)

Oxurion (Belgium)

What are the most cited papers from Oxurion (Belgium)?

The most cited paper from Oxurion (Belgium) is "Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis" (Kateřina Rohlenová et al., 2020), with 332 citations. Next come "Therapeutic depletion of CCR8 + tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy" (213) and "Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop" (167).

Published TypeFieldAccessCitations

Showing 41 of 41 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Single-Cell RNA Sequencing Maps Endothelial Metabolic Plasticity in Pathological Angiogenesis Kateřina Rohlenová et al. · Cell Metabolism Open access	Apr 2020	332
2	Therapeutic depletion of CCR8 + tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy Helena Van Damme et al. · Journal for ImmunoTherapy of Cancer Open access	Feb 2021	213
3	Cancer immunotherapies transition endothelial cells into HEVs that generate TCF1+ T lymphocyte niches through a feed-forward loop Yichao Hua et al. · Cancer Cell Open access	23 Nov 2022	167
4	Common pathways in dementia and diabetic retinopathy: understanding the mechanisms of diabetes-related cognitive decline Karis Little et al. · Trends in Endocrinology and Metabolism ReviewOpen access	15 Nov 2021	133
5	The role of placental growth factor (PlGF) and its receptor system in retinal vascular diseases Tine Van Bergen, Isabelle Étienne, Fiona M Cunningham et al. · Progress in Retinal and Eye Research	29 Oct 2018	116
6	Single-cell transcriptome analysis of the Akimba mouse retina reveals cell-type-specific insights into the pathobiology of diabetic retinopathy Inge Van Hove, Lies De Groef, Bram Boeckx et al. · Diabetologia Open access	30 Jul 2020	113
7	Longitudinal In Vivo Characterization of the Streptozotocin-Induced Diabetic Mouse Model: Focus on Early Inner Retinal Responses Jurgen Sergeys, Isabelle Étienne, Inge Van Hove et al. · Investigative Ophthalmology & Visual Science Open access	27 Feb 2019	107
8	Targeting RGD-binding integrins as an integrative therapy for diabetic retinopathy and neovascular age-related macular degeneration Inge Van Hove, Tjing‐Tjing Hu, Karen Beets et al. · Progress in Retinal and Eye Research Open access	26 Mar 2021	75
9	The killifish visual system as an in vivo model to study brain aging and rejuvenation Sophie Vanhunsel, Steven Bergmans, An Beckers et al. · npj Aging and Mechanisms of Disease Open access	17 Aug 2021	56
10	The potent small molecule integrin antagonist THR-687 is a promising next-generation therapy for retinal vascular disorders Tjing‐Tjing Hu, Marc Vanhove, Michaël Porcu et al. · Experimental Eye Research	22 Nov 2018	35
11	The age factor in optic nerve regeneration: Intrinsic and extrinsic barriers hinder successful recovery in the short‐living killifish Sophie Vanhunsel, Steven Bergmans, An Beckers et al. · Aging Cell Open access	19 Dec 2021	33
12	Dysregulation of the kallikrein-kinin system in bronchoalveolar lavage fluid of patients with severe COVID-19 Caroline P. Martens et al. · EBioMedicine Open access	5 Aug 2022	32
13	Phase I trial on robot assisted retinal vein cannulation with ocriplasmin infusion for central retinal vein occlusion Koen Willekens, Andy Gijbels, J. M. M. Smits et al. · Acta Ophthalmologica Open access	23 Jul 2020	26
14	Tightening the retinal glia limitans attenuates neuroinflammation after optic nerve injury Evy Lefevere, Manuel Salinas‐Navarro, Lien Andries et al. · Glia Open access	9 Jul 2020	25
15	Phase 1 Study of THR-687, a Novel, Highly Potent Integrin Antagonist for the Treatment of Diabetic Macular Edema Arshad M. Khanani, Sunil S. Patel, Víctor H. González et al. · Ophthalmology Science Open access	14 Jul 2021	23
16	Phase 1 Dose-Escalation Study of Plasma Kallikrein Inhibitor THR-149 for the Treatment of Diabetic Macular Edema Pravin U. Dugel, Arshad M. Khanani, Brian B. Berger et al. · Translational Vision Science & Technology Open access	23 Dec 2021	18
17	The Placental Growth Factor Pathway and Its Potential Role in Macular Degenerative Disease Fiona M Cunningham, Tine Van Bergen, Paul E. Canning et al. · Current Eye Research	6 May 2019	17
18	OCRIPLASMIN FOR VITREOMACULAR TRACTION IN CLINICAL PRACTICE DAVID H. STEEL, Niall Patton, Theodor Stappler et al. · Retina Open access	2 Jun 2020	15
19	KD determination from time-resolved experiments on live cells with LigandTracer and reconciliation with end-point flow cytometry measurements Diana Spiegelberg, Jonas Stenberg, Pascale Richalet et al. · European Biophysics Journal Open access	24 Jul 2021	12
20	The retinal tyrosine kinome of diabetic Akimba mice highlights potential for specific Src family kinase inhibition in retinal vascular disease Jurgen Sergeys, Inge Van Hove, Tjing‐Tjing Hu et al. · Experimental Eye Research Open access	23 Jun 2020	12
21	Heparanase Deficiency Is Associated with Disruption, Detachment, and Folding of the Retinal Pigment Epithelium Tine Van Bergen, Isabelle Étienne, Juan Jia et al. · Current Eye Research Open access	29 Dec 2020	11
22	PATIENT-REPORTED VISUAL FUNCTION FROM THE OCRIPLASMIN FOR TREATMENT FOR SYMPTOMATIC VITREOMACULAR ADHESION, INCLUDING MACULAR HOLE (OASIS) STUDY Calvin E. Mein, Pravin U. Dugel, Leonard Feiner et al. · Retina Open access	25 Jun 2019	10
23	Targeting Plasma Kallikrein With a Novel Bicyclic Peptide Inhibitor (THR-149) Reduces Retinal Thickening in a Diabetic Rat Model Tine Van Bergen, Tjing‐Tjing Hu, Karis Little et al. · Investigative Ophthalmology & Visual Science Open access	22 Oct 2021	9
24	Calculating the individual probability of successful ocriplasmin treatment in eyes with vitreomacular traction–Validation and refinement of a multivariable prediction model Christoph C. Paul, Hans‐Helge Müller, Thomas Raber et al. · PLoS ONE Open access	25 Jul 2022	6
25	Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 2. THR-687 Marc Vanhove, Jean-Marc Wagner, Bernard Noppen et al. · Journal of Pharmacokinetics and Pharmacodynamics Open access	23 Jul 2021	6
26	A novel assay based on pre-equilibrium titration curves for the determination of enzyme inhibitor binding kinetics Bernard Noppen, Anouk Vanbelle, Alan W. Stitt et al. · European Biophysics Journal Open access	22 Jun 2021	6
27	Prognostic Factors Associated with Ocriplasmin Efficacy for the Treatment of Symptomatic Vitreomacular Adhesion and Full-thickness Macular Hole: Analysis from Four Studies Brian C. Joondeph, Paul C. P. H. Willems, Thomas Raber et al. · Journal of Ophthalmic and Vision Research Open access	20 Jan 2021	5
28	Predicting the individual probability of macular hole closure following intravitreal ocriplasmin injections for vitreomacular traction release using baseline characteristics Thomas Bertelmann, Lars Berndzen, Thomas Raber et al. · Scientific Reports Open access	16 Dec 2021	3
29	A method to assess the robustness of complex mathematical models used for quantitative interpretation of experimental data by nonlinear regression analysis: application to high-affinity binding models Marc Vanhove · European Biophysics Journal	17 Jun 2021	3
30	Resolution of outer retinal abnormalities in eyes with vitreomacular traction without macular hole in the OASIS trial Akshay S. Thomas, Luc Duchateau, Petra Kozma-Wiebe et al. · British Journal of Ophthalmology	14 Mar 2022	2
31	Anticancer immunotherapies transition postcapillary venules into high-endothelial venules that generate TCF1+ T lymphocyte niches through a feed-forward loop Yichao Hua, Gerlanda Vella, Florian Rambow et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access	24 Dec 2021	2
32	Systemic exposure following intravitreal administration of therapeutic agents: an integrated pharmacokinetic approach. 1. THR-149 Marc Vanhove, Bernard Noppen, Jean-Marc Wagner et al. · Journal of Pharmacokinetics and Pharmacodynamics Open access	23 Jul 2021	2
33	IL-33trap-mediated IL-33 neutralization does not exacerbate choroidal neovascularization, but fails to protect against retinal degeneration in a dry age-related macular degeneration model Inge Van Hove, Tine Van Bergen, Isabelle Étienne et al. · Experimental Eye Research	27 Apr 2021	1
34	Placental growth factor (PlGF) induced signalling regulates barrier properties of the retinal pigment epithelium (RPE) Fiona M Cunningham, Paul E. Canning, Tine Van Bergen et al. · Research Portal (Queen's University Belfast) Conference paperOpen access	22 Jul 2019	1
35	Cell‐type specific insights into the pathobiology of advanced diabetic retinopathy using single‐cell transcriptome analysis of the Akimba retina Inge Van Hove, Michaël Porcu, Lies De Groef et al. · Acta Ophthalmologica	Dec 2019	1
36	The effect of combined PlGF and VEGF inhibition on vascular leakage and inflammation in experimental murine models Tine Van Bergen, Tjing‐Tjing Hu, Isabelle Étienne et al. · Investigative Ophthalmology & Visual Science Open access	22 Jul 2019	0
37	A potential role for Src during early experimental diabetic retinopathy? Jurgen Sergeys, Isabelle Étienne, Evy Lefevere et al. · Lirias Open access	30 Apr 2019	0
38	The Mouse Sodium Iodate Model Exhibits Acute Retinal Inflammation Karen Beets, Michaël Porcu, Tjing‐Tjing Hu et al. · Investigative Ophthalmology & Visual Science Open access	21 Jun 2021	0
39	Retrospective Study of Ellipsoid Zone Integrity Following Treatment with Intravitreal Ocriplasmin (OZONE Study) Kimberly A. Drenser, Dante J Pieramici, Joseph M Gunn et al. · Clinical ophthalmology Open access	Jul 2021	0
40	The role of placental growth factor (PlGF) in retinal pigment epithelial (RPE) barrier integrity and outer retinal integrity in geographic atrophy Fiona M Cunningham, Tine Van Bergen, Jean H.M. Feyen et al. · Investigative Ophthalmology & Visual Science Open access	21 Jun 2021	0
41	The potent integrin antagonist THR‐687 is a promising next‐generation drug candidate for the treatment of multifactorial retinal diseases Tjing‐Tjing Hu, Tine Van Bergen, Isabelle Étienne et al. · Acta Ophthalmologica	Dec 2019	0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.